The Cancer Letter

Inside information on cancer research and drug development

In Brief

Mount Sinai Health System and BronxCare Health System open cancer facility

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Mount Sinai Health System and BronxCare Health System have launched BronxCare Mount Sinai Comprehensive Cancer Care—a new comprehensive cancer facility in the Bronx. 

The 10,000 square f00t space houses medical oncology, surgical oncology, and support services, and an expanded treatment area with dedicated chemotherapy and immunotherapy infusion suites. 

Kevin R. Jain, section chief of medical oncology and hematology at BronxCare Health System, will direct the center. 

The facility’s staff includes five medical oncologists and hematologists, five general surgeons, two surgical oncologists, two thoracic surgeons, two radiation oncologists, two neurosurgeons, four urologists, one social worker, two oncology-specialized ENT surgeons, an oncology-certified nursing team, two board-certified oncology pharmacists, an oncology pharmacy residency training program, and a team of administrative and support staff.

Table of Contents

YOU MAY BE INTERESTED IN

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
By Melinda Krigel
Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
By NRG Staff
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account